1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil structure
|
Common Name | 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil | ||
|---|---|---|---|---|
| CAS Number | 2095417-68-6 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil |
|---|
| Description | 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| InChIKey | XMTQDCPOXBNCIJ-PEBGCTIMSA-N |
|---|---|
| SMILES | COC1C(O)C(CCP(=O)(O)O)OC1n1ccc(=O)[nH]c1=O |